期刊文献+

婴儿胆汁淤积性肝病的营养管理 被引量:10

Nutritional management of infantile cholestatic liver disease
原文传递
导出
摘要 胆汁淤积性肝病是婴儿期肝病最常见的类型,营养不良是该类疾病患儿的常见问题,不仅显著影响婴儿的生长发育,还可导致神经认知障碍,部分慢性胆汁淤积性肝病患儿在疾病终末期需接受肝脏移植治疗,营养不良会导致移植并发症和病死率显著增高,因此,对于婴儿胆汁淤积性肝病患儿需积极采取恰当营养管理,以改善预后。 Cholestatic liver disease is the most common type of infantile liver disease, and malnutrition is very common in infantile cholestatic liver disease, which may seriously affect the growth and development of infants, and even lead to neuro-cognitive impairment.Some children with chronic cholestatic liver disease need liver transplantation at the end of the disease, while malnutrition might cause more complications and higher mortality.In order to improve the prognosis, active and appropriate nutritional management is considerably needed.
作者 舒赛男 黄志华 Shu Sainan;Huang Zhihua(Department of Pediatrics, Tongji Hospital, Tongji Medical College, Hiuizhong University of Science & Technology, Wuhan430030, China)
出处 《中华实用儿科临床杂志》 CSCD 北大核心 2019年第7期488-491,共4页 Chinese Journal of Applied Clinical Pediatrics
关键词 营养管理 胆汁淤积性肝病 婴儿 Nutritional management Cholestatic liver disease Infant
  • 相关文献

参考文献4

二级参考文献43

  • 1Greaves MW. Recent advances in pathopbysiology and current management of itch[J]. An Acad Med, 2007,36:788-792.
  • 2Kenneth DRS, Nancy O' Connell. Disorders of bile acid synthe- sis and metabolism: a metabolic basis for liver disease [M]// Suchy FJ, Sokol RJ, Balistreri WF. Liver Disease in Chil- dren.3rd ed. Cambridge University Press, 2007:736-766.
  • 3Kakizaki S, Takizawa D, Tojima H, et al. Nuclear receptors CAR and PXR: therapeutic targets for cholestatic liver dis- ease[J].Frontiers Biosci, 201 l, 16:2988-3003.
  • 4Geier A, Fickert P, Trauner M. Mechanisms of disease: mecha- nisms and clinical implications of cholestasis in sepsis [J]. Nat Clin Pract Gastroenter Hepat,2006 , 3( 10):574-585.
  • 5Hayasaka K, Numakura C, Toyota K, et al. Treatment with lac- tose (galactose)-restricted and medium-chain triglyceride-sup- plemented formula for neonatal intrahepatic cholestasis causedby citrin defieiency[J].JIMD Rep,2012,2:37-44.
  • 6Bhogal HK, Sanyal AJ. The molecular pathogenesis of cholcsta- sis in sepsis[J]. Frontier Biosei, 2013,5:87-96.
  • 7Premkumar MH, Carter BA, Hawthorne KM, et al. High rates of resolution of eholestasis in parenteral nutrition-associated liv- er disease with fish oil-based lipid emulsion monotherapy [J]. J Pediatr, S0022-3476 (12) :01189-4.
  • 8Li MK, CrawfordJM.The pathology of eholestasis [J]. Semin Liv- er Dis,2004, 24( 1 ):21-42.
  • 9Leikowitch JH.Scheuer' s liver biopsy interpretation [M].8th ed. Saunders (W.B.) Co Ltd,2010:48.
  • 10Padda MS, Sanchez M, Akhtar AJ, et al. Drug-induced cho-lestasis[J]. Hepatology,2011,53(3):1377-1387.

共引文献60

同被引文献78

引证文献10

二级引证文献14

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部